(Q46416699)

22 December 2017

title

Effects of intraperitoneal injection of Rofecoxib in a mouse model of ALS. (English)

1 reference

22 December 2017

amyotrophic lateral sclerosis

main subject

1 reference

based on heuristic

inferred from title

author

Michael Richard Le Grande

3

1 reference

22 December 2017

author name string

M F Azari

1

1 reference

22 December 2017

C Profyris

2

1 reference

22 December 2017

E C Lopes

4

1 reference

22 December 2017

J Hirst

5

1 reference

22 December 2017

S Petratos

6

1 reference

22 December 2017

S S Cheema

7

1 reference

22 December 2017

publication date

1 May 2005

1 reference

22 December 2017

European Journal of Neurology

published in

1 reference

22 December 2017

volume

12

1 reference

22 December 2017

issue

5

1 reference

22 December 2017

page(s)

357-364

1 reference

22 December 2017

Increased levels of the pro-inflammatory prostaglandin PGE2 in CSF from ALS patients

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2004.00987.X

From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2004.00987.X

Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu,Zn SOD, and in mice overexpressing wild type human SOD: a model of familial amyotrophic lateral sclerosis (FALS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2004.00987.X

Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2004.00987.X

Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2004.00987.X

Prostaglandin E2 is increased in amyotrophic lateral sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2004.00987.X

The selective cyclooxygenase-2 inhibitor rofecoxib reduces kainate-induced cell death in the rat hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2004.00987.X

Expression and localization of cyclooxygenase‐1 and ‐2 in human sporadic amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2004.00987.X

Inflammatory processes in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2004.00987.X

Therapeutic advances in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2004.00987.X

Prostaglandin D2 in rat brain, spinal cord and pituitary: basal level and regional distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2004.00987.X

Functional switch between motor tracts in the presence of the mAb IN-1 in the adult rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2004.00987.X

N-methyl-D-aspartate receptor-mediated mitochondrial Ca(2+) overload in acute excitotoxic motor neuron death: a mechanism distinct from chronic neurotoxicity after Ca(2+) influx

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2004.00987.X

10.1111/J.1468-1331.2004.00987.X

21 January 2018

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017